Review

CRISIL LTD.

Ticker : 500092
FV : Rs 1
52-Week H/L : Rs 2,125.00/1,083.50

We had previously recommended CRISIL in volume 37, issue no. 12, dated January 11, 2021, when the scrip was trading at Rs 1,941.45. It was recommended based on the company’s robust growth. CRISIL Ltd is a leading analytical company that provides services such as ratings, data & research, ana- lytics, and solutions. Looking at the quarterly financial front on a consolidated basis, for Q3FY21, its net sales increased by 28.64 per cent to Rs 597.24 crore from Rs 464.29 crore reported for Q3FY20. PBDT came in at Rs 165.35 crore for Q3FY21, which is a rise of 16.91 per cent compared to Rs 141.43 crore for Q3FY20. The company reported a net profit of Rs 110.04 crore for Q3FY21, increasing by 15.43 per cent from the net profit of Rs 95.33 crore reported in Q3FY20. The company continues to win new clients thereby, achieving strong business growth. Considering its positive future prospects, we recommend-HOLD.